Lung development starts in utero and continues during childhood through to adolescence,
reaching its peak in early adulthood. This growth is followed by gradual decline due to …

Background Asthma is a heterogeneous disease characterized by distinct phenotypes with
associated microbial dysbiosis. Objectives Our aim was to identify severe asthma …

Rationale: Mast cells (MCs) play a role in inflammation and both innate and adaptive
immunity, but their involvement in severe asthma (SA) remains undefined. Objectives: We …

Background Interleukin (IL)‐33 is an upstream regulator of type 2 (T2) eosinophilic
inflammation and has been proposed as a key driver of some asthma phenotypes. Objective To …

Background Transcriptomic changes in patients who respond clinically to biological therapies
may identify responses in other tissues or diseases. Objective We sought to determine …

Background Macrophages control innate and acquired immunity, but their role in severe
asthma remains ill‐defined. We investigated gene signatures of macrophage subtypes in the …

Background Patients with severe asthma may have a greater risk of dying from COVID-19
disease. Angiotensin converting enzyme-2 (ACE2) and the enzyme proteases, …

To the Editor, Asthma is a complex heterogeneous disease that presents with varying degrees
of severity. Analysis of the transcriptome of sputum cells from asthma patients has defined …

Background Conservative management is an option for prostate cancer (PCa) patients either
with the objective of delaying or even avoiding curative therapy, or to wait until palliative …

Background Allergen source‐derived proteases are a critical factor in the formation and
development of asthma. The cysteine protease activity of house dust mite (HDM) disrupts the …